Sasha Wahab, MD
Radiation Oncology · Stockbridge, GANPI 1053438762
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,800 of the $2,150 with a category attached, or 83.7%. Davol Inc. accounts for 83.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,800 and has fallen 96.3% since, to $67 in 2025.
Across 11 payments — averaging $195.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$2K
- Boston Scientific$116
- Brainlab, Inc.$93
- Regeneron Healthcare Solutions, Inc.$50
- Elekta, Inc.$38
- Sumitomo Pharma America, Inc.$20
- plus $32 from 2 others
What the payments were for
- Speaking & faculty fees$1,80084%
- Food & beverage$35016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 1 | $1,800 |
| Boston Scientific | 3 | $116 |
| Brainlab, Inc. | 1 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Elekta, Inc. | 1 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $17 |
| Angiodynamics, Inc. | 1 | $15 |
How this compares
$2,150 in reported general payments places this provider in the 80th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 59 | $505 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $401 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Stockbridge
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
- Adam NowlanAtlanta$11K
- Ashesh JaniAtlanta$10K
- Mark McLaughlinMarietta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.